Clinical Trial Update: Safety and Efficacy of Gabapentin in Postherpetic Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 study of gabapentin for postherpetic neuralgia has completed. The update reports on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Depomed | Conditions: Neuralgia, Postherpetic | Phase 3 | Status: COMPLETED